Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsEurope plus one

    Europe Plus One

    Jump to

    • Himadri Speciality: Little comfort on valuation

      In the near term, HSCL could continue to benefit from the demand-supply mismatch in Europe. HSCL’s long-term plan is to diversify into new-age businesses. This can have a long gestation period and face technological challenges

    • Stock Of The Day: Ami Organics To Ride The Europe Plus One Trend

      The dominant presence in some of the pharma intermediate molecules. ‘Europe plus one’ is taking traction for Chemicals. Multi-year contract with Fermion for one of its patented products. Gained traction in the electrolyte additives business. Gradual pickup in pharma demand after a recent lull. In specialty chemicals, company is expanding on the clientele side.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347